Press release content from PR Newswire. The AP news staff was not involved in its creation.
Mitsubishi Tanabe Pharma America Celebrates Five Years of Dedication to the ALS Community in the U.S.
February 8, 2021 GMT
MTPA Logo (PRNewsfoto/Mitsubishi Tanabe Pharma Americ)
JERSEY CITY, N.J., Feb. 8, 2021 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today celebrated its five-year anniversary of being established in the United States in 2016. MTPA has followed an unwavering patient-first philosophy focused on advancing innovative treatments for people facing serious and life-threatening diseases, including amyotrophic lateral sclerosis (ALS).
“Having personally been a part of the MTPA journey from the beginning, I am humbled by what we have achieved as one team, with one mission: helping patients,” said Atsushi Fujimoto, President, MTPA. “We have accomplished many things in the first five years working together to serve the ALS community, and we look forward to seeing the journey ahead over the next five years as we continue to expand our product pipeline and strengthen our support of people who suffer from ALS and other debilitating conditions.”